市場調查報告書

抗生素的全球市場

Antibiotics

出版商 Global Industry Analysts, Inc. 商品編碼 912509
出版日期 內容資訊 英文 352 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
抗生素的全球市場 Antibiotics
出版日期: 2019年10月01日內容資訊: 英文 352 Pages
簡介

本報告提供全球抗生素市場概要,彙整趨勢·發展的影響因素分析,競爭企業與市場佔有率,世界及地區·各主要國家的市場規模的變化與預測,主要企業簡介等資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要
    • 全球市場的企業佔有率
    • 全球抗生素市場上企業佔有率方案
  • 主要企業
  • 市場趨勢與發展因素
  • 全球市場預測

第3章 市場分析

  • 各地區市場分析
    • 美國
    • 加拿大
    • 日本
    • 中國
    • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 西班牙
    • 俄羅斯
    • 其他歐洲
    • 亞太地區
    • 澳洲
    • 印度
    • 韓國
    • 其他亞太地區
    • 南美
    • 阿根廷
    • 巴西
    • 墨西哥
    • 其他南美國家
    • 中東
    • 伊朗
    • 以色列
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東
    • 非洲

第4章 競爭企業

  • ABBOTT LABORATORIES
  • ALLERGAN PLC
  • AUROBINDO PHARMA
  • BAYER AG
  • ELI LILLY AND COMPANY
  • F. HOFFMANN-LA ROCHE AG
  • GLAXOSMITHKLINE PLC
  • LUPIN PHARMACEUTICALS
  • MERCK & CO., INC.
  • MYLAN NV
  • NOVARTIS INTERNATIONAL AG
  • PFIZER
  • SANOFI
  • SHIONOGI, INC.
  • SUN PHARMACEUTICAL INDUSTRIES
  • TEVA PHARMACEUTICAL INDUSTRIES

第5章 調查資料

目錄
Product Code: MCP-1705

Antibiotics market worldwide is projected to grow by US$7.2 Billion, driven by a compounded growth of 2.3%. Beta Lactam & Beta Lactamase Inhibitors, one of the segments analyzed and sized in this study, displays the potential to grow at over 2.7%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$20.5 Billion by the year 2025, Beta Lactam & Beta Lactamase Inhibitors will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 1.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$282 Million to the region's size and clout in the next 5 to 6 years. Over US$212.2 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Beta Lactam & Beta Lactamase Inhibitors will reach a market size of US$1.2 Billion by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 3.7% over the next couple of years and add approximately US$2 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,, Abbott Laboratories, Inc.; Allergan PLC; Aurobindo Pharma Ltd.; Bayer AG; Eli Lilly and Company; F. Hoffmann-La Roche AG; GlaxoSmithKline PLC; Lupin Pharmaceuticals, Inc.; Merck & Co., Inc.; Mylan NV; Novartis International AG; Pfizer, Inc.; Sanofi; Shionogi, Inc.; Sun Pharmaceutical Industries Ltd.; Teva Pharmaceutical Industries Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Antibiotics Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Antibiotics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Antibiotics Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Antibiotics Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Beta Lactam & Beta Lactamase Inhibitors (Drug Class) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 5: Beta Lactam & Beta Lactamase Inhibitors (Drug Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 6: Beta Lactam & Beta Lactamase Inhibitors (Drug Class) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Quinolone (Drug Class) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 8: Quinolone (Drug Class) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 9: Quinolone (Drug Class) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 10: Macrolide (Drug Class) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
  • TABLE 11: Macrolide (Drug Class) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
  • TABLE 12: Macrolide (Drug Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 13: Other Classes (Drug Class) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
  • TABLE 14: Other Classes (Drug Class) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 15: Other Classes (Drug Class) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 16: Natural (Drug Origin) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 17: Natural (Drug Origin) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 18: Natural (Drug Origin) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 19: Semisynthetic (Drug Origin) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025
  • TABLE 20: Semisynthetic (Drug Origin) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 21: Semisynthetic (Drug Origin) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 22: Synthetic (Drug Origin) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2018 to 2025
  • TABLE 23: Synthetic (Drug Origin) Global Historic Demand in US$ Million by Region/Country: 2009 to 2017
  • TABLE 24: Synthetic (Drug Origin) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 25: Oral (Route of Administration) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 26: Oral (Route of Administration) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 27: Oral (Route of Administration) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 28: Intravenous (Route of Administration) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 29: Intravenous (Route of Administration) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 30: Intravenous (Route of Administration) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 31: Other Route of Administrations (Route of Administration) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
  • TABLE 32: Other Route of Administrations (Route of Administration) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
  • TABLE 33: Other Route of Administrations (Route of Administration) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Antibiotics Market Share (in %) by Company: 2019 & 2025
    • TABLE 34: United States Antibiotics Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
    • TABLE 35: Antibiotics Market in the United States by Drug Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 36: United States Antibiotics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 37: United States Antibiotics Market Estimates and Projections in US$ Million by Drug Origin: 2018 to 2025
    • TABLE 38: Antibiotics Market in the United States by Drug Origin: A Historic Review in US$ Million for 2009-2017
    • TABLE 39: United States Antibiotics Market Share Breakdown by Drug Origin: 2009 VS 2019 VS 2025
    • TABLE 40: United States Antibiotics Market Estimates and Projections in US$ Million by Route of Administration: 2018 to 2025
    • TABLE 41: Antibiotics Market in the United States by Route of Administration: A Historic Review in US$ Million for 2009-2017
    • TABLE 42: United States Antibiotics Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 43: Canadian Antibiotics Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
    • TABLE 44: Canadian Antibiotics Historic Market Review by Drug Class in US$ Million: 2009-2017
    • TABLE 45: Antibiotics Market in Canada: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
    • TABLE 46: Canadian Antibiotics Market Estimates and Forecasts in US$ Million by Drug Origin: 2018 to 2025
    • TABLE 47: Canadian Antibiotics Historic Market Review by Drug Origin in US$ Million: 2009-2017
    • TABLE 48: Antibiotics Market in Canada: Percentage Share Breakdown of Sales by Drug Origin for 2009, 2019, and 2025
    • TABLE 49: Canadian Antibiotics Market Estimates and Forecasts in US$ Million by Route of Administration: 2018 to 2025
    • TABLE 50: Canadian Antibiotics Historic Market Review by Route of Administration in US$ Million: 2009-2017
    • TABLE 51: Antibiotics Market in Canada: Percentage Share Breakdown of Sales by Route of Administration for 2009, 2019, and 2025
  • JAPAN
    • TABLE 52: Japanese Market for Antibiotics: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 53: Antibiotics Market in Japan: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
    • TABLE 54: Japanese Antibiotics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 55: Japanese Market for Antibiotics: Annual Sales Estimates and Projections in US$ Million by Drug Origin for the Period 2018-2025
    • TABLE 56: Antibiotics Market in Japan: Historic Sales Analysis in US$ Million by Drug Origin for the Period 2009-2017
    • TABLE 57: Japanese Antibiotics Market Share Analysis by Drug Origin: 2009 VS 2019 VS 2025
    • TABLE 58: Japanese Market for Antibiotics: Annual Sales Estimates and Projections in US$ Million by Route of Administration for the Period 2018-2025
    • TABLE 59: Antibiotics Market in Japan: Historic Sales Analysis in US$ Million by Route of Administration for the Period 2009-2017
    • TABLE 60: Japanese Antibiotics Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 61: Chinese Antibiotics Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 62: Antibiotics Historic Market Analysis in China in US$ Million by Drug Class: 2009-2017
    • TABLE 63: Chinese Antibiotics Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 64: Chinese Antibiotics Market Growth Prospects in US$ Million by Drug Origin for the Period 2018-2025
    • TABLE 65: Antibiotics Historic Market Analysis in China in US$ Million by Drug Origin: 2009-2017
    • TABLE 66: Chinese Antibiotics Market by Drug Origin: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 67: Chinese Antibiotics Market Growth Prospects in US$ Million by Route of Administration for the Period 2018-2025
    • TABLE 68: Antibiotics Historic Market Analysis in China in US$ Million by Route of Administration: 2009-2017
    • TABLE 69: Chinese Antibiotics Market by Route of Administration: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Antibiotics Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 70: European Antibiotics Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 71: Antibiotics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 72: European Antibiotics Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 73: European Antibiotics Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
    • TABLE 74: Antibiotics Market in Europe in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 75: European Antibiotics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 76: European Antibiotics Market Estimates and Forecasts in US$ Million by Drug Origin: 2018-2025
    • TABLE 77: Antibiotics Market in Europe in US$ Million by Drug Origin: A Historic Review for the Period 2009-2017
    • TABLE 78: European Antibiotics Market Share Breakdown by Drug Origin: 2009 VS 2019 VS 2025
    • TABLE 79: European Antibiotics Market Estimates and Forecasts in US$ Million by Route of Administration: 2018-2025
    • TABLE 80: Antibiotics Market in Europe in US$ Million by Route of Administration: A Historic Review for the Period 2009-2017
    • TABLE 81: European Antibiotics Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 82: Antibiotics Market in France by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 83: French Antibiotics Historic Market Scenario in US$ Million by Drug Class: 2009-2017
    • TABLE 84: French Antibiotics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 85: Antibiotics Market in France by Drug Origin: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 86: French Antibiotics Historic Market Scenario in US$ Million by Drug Origin: 2009-2017
    • TABLE 87: French Antibiotics Market Share Analysis by Drug Origin: 2009 VS 2019 VS 2025
    • TABLE 88: Antibiotics Market in France by Route of Administration: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 89: French Antibiotics Historic Market Scenario in US$ Million by Route of Administration: 2009-2017
    • TABLE 90: French Antibiotics Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 91: Antibiotics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 92: German Antibiotics Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 93: German Antibiotics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 94: Antibiotics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Drug Origin for the Period 2018-2025
    • TABLE 95: German Antibiotics Historic Market Analysis in US$ Million by Drug Origin: 2009-2017
    • TABLE 96: German Antibiotics Market Share Breakdown by Drug Origin: 2009 VS 2019 VS 2025
    • TABLE 97: Antibiotics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Route of Administration for the Period 2018-2025
    • TABLE 98: German Antibiotics Historic Market Analysis in US$ Million by Route of Administration: 2009-2017
    • TABLE 99: German Antibiotics Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 100: Italian Antibiotics Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 101: Antibiotics Historic Market Analysis in Italy in US$ Million by Drug Class: 2009-2017
    • TABLE 102: Italian Antibiotics Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 103: Italian Antibiotics Market Growth Prospects in US$ Million by Drug Origin for the Period 2018-2025
    • TABLE 104: Antibiotics Historic Market Analysis in Italy in US$ Million by Drug Origin: 2009-2017
    • TABLE 105: Italian Antibiotics Market by Drug Origin: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 106: Italian Antibiotics Market Growth Prospects in US$ Million by Route of Administration for the Period 2018-2025
    • TABLE 107: Antibiotics Historic Market Analysis in Italy in US$ Million by Route of Administration: 2009-2017
    • TABLE 108: Italian Antibiotics Market by Route of Administration: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 109: United Kingdom Market for Antibiotics: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 110: Antibiotics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
    • TABLE 111: United Kingdom Antibiotics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 112: United Kingdom Market for Antibiotics: Annual Sales Estimates and Projections in US$ Million by Drug Origin for the Period 2018-2025
    • TABLE 113: Antibiotics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Drug Origin for the Period 2009-2017
    • TABLE 114: United Kingdom Antibiotics Market Share Analysis by Drug Origin: 2009 VS 2019 VS 2025
    • TABLE 115: United Kingdom Market for Antibiotics: Annual Sales Estimates and Projections in US$ Million by Route of Administration for the Period 2018-2025
    • TABLE 116: Antibiotics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Route of Administration for the Period 2009-2017
    • TABLE 117: United Kingdom Antibiotics Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025
  • SPAIN
    • TABLE 118: Spanish Antibiotics Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
    • TABLE 119: Spanish Antibiotics Historic Market Review by Drug Class in US$ Million: 2009-2017
    • TABLE 120: Antibiotics Market in Spain: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
    • TABLE 121: Spanish Antibiotics Market Estimates and Forecasts in US$ Million by Drug Origin: 2018 to 2025
    • TABLE 122: Spanish Antibiotics Historic Market Review by Drug Origin in US$ Million: 2009-2017
    • TABLE 123: Antibiotics Market in Spain: Percentage Share Breakdown of Sales by Drug Origin for 2009, 2019, and 2025
    • TABLE 124: Spanish Antibiotics Market Estimates and Forecasts in US$ Million by Route of Administration: 2018 to 2025
    • TABLE 125: Spanish Antibiotics Historic Market Review by Route of Administration in US$ Million: 2009-2017
    • TABLE 126: Antibiotics Market in Spain: Percentage Share Breakdown of Sales by Route of Administration for 2009, 2019, and 2025
  • RUSSIA
    • TABLE 127: Russian Antibiotics Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
    • TABLE 128: Antibiotics Market in Russia by Drug Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 129: Russian Antibiotics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 130: Russian Antibiotics Market Estimates and Projections in US$ Million by Drug Origin: 2018 to 2025
    • TABLE 131: Antibiotics Market in Russia by Drug Origin: A Historic Review in US$ Million for 2009-2017
    • TABLE 132: Russian Antibiotics Market Share Breakdown by Drug Origin: 2009 VS 2019 VS 2025
    • TABLE 133: Russian Antibiotics Market Estimates and Projections in US$ Million by Route of Administration: 2018 to 2025
    • TABLE 134: Antibiotics Market in Russia by Route of Administration: A Historic Review in US$ Million for 2009-2017
    • TABLE 135: Russian Antibiotics Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 136: Rest of Europe Antibiotics Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
    • TABLE 137: Antibiotics Market in Rest of Europe in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 138: Rest of Europe Antibiotics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 139: Rest of Europe Antibiotics Market Estimates and Forecasts in US$ Million by Drug Origin: 2018-2025
    • TABLE 140: Antibiotics Market in Rest of Europe in US$ Million by Drug Origin: A Historic Review for the Period 2009-2017
    • TABLE 141: Rest of Europe Antibiotics Market Share Breakdown by Drug Origin: 2009 VS 2019 VS 2025
    • TABLE 142: Rest of Europe Antibiotics Market Estimates and Forecasts in US$ Million by Route of Administration: 2018-2025
    • TABLE 143: Antibiotics Market in Rest of Europe in US$ Million by Route of Administration: A Historic Review for the Period 2009-2017
    • TABLE 144: Rest of Europe Antibiotics Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 145: Asia-Pacific Antibiotics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 146: Antibiotics Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 147: Asia-Pacific Antibiotics Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 148: Antibiotics Market in Asia-Pacific by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 149: Asia-Pacific Antibiotics Historic Market Scenario in US$ Million by Drug Class: 2009-2017
    • TABLE 150: Asia-Pacific Antibiotics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 151: Antibiotics Market in Asia-Pacific by Drug Origin: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 152: Asia-Pacific Antibiotics Historic Market Scenario in US$ Million by Drug Origin: 2009-2017
    • TABLE 153: Asia-Pacific Antibiotics Market Share Analysis by Drug Origin: 2009 VS 2019 VS 2025
    • TABLE 154: Antibiotics Market in Asia-Pacific by Route of Administration: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 155: Asia-Pacific Antibiotics Historic Market Scenario in US$ Million by Route of Administration: 2009-2017
    • TABLE 156: Asia-Pacific Antibiotics Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025
  • AUSTRALIA
    • TABLE 157: Antibiotics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 158: Australian Antibiotics Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 159: Australian Antibiotics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 160: Antibiotics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Drug Origin for the Period 2018-2025
    • TABLE 161: Australian Antibiotics Historic Market Analysis in US$ Million by Drug Origin: 2009-2017
    • TABLE 162: Australian Antibiotics Market Share Breakdown by Drug Origin: 2009 VS 2019 VS 2025
    • TABLE 163: Antibiotics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Route of Administration for the Period 2018-2025
    • TABLE 164: Australian Antibiotics Historic Market Analysis in US$ Million by Route of Administration: 2009-2017
    • TABLE 165: Australian Antibiotics Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025
  • INDIA
    • TABLE 166: Indian Antibiotics Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
    • TABLE 167: Indian Antibiotics Historic Market Review by Drug Class in US$ Million: 2009-2017
    • TABLE 168: Antibiotics Market in India: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
    • TABLE 169: Indian Antibiotics Market Estimates and Forecasts in US$ Million by Drug Origin: 2018 to 2025
    • TABLE 170: Indian Antibiotics Historic Market Review by Drug Origin in US$ Million: 2009-2017
    • TABLE 171: Antibiotics Market in India: Percentage Share Breakdown of Sales by Drug Origin for 2009, 2019, and 2025
    • TABLE 172: Indian Antibiotics Market Estimates and Forecasts in US$ Million by Route of Administration: 2018 to 2025
    • TABLE 173: Indian Antibiotics Historic Market Review by Route of Administration in US$ Million: 2009-2017
    • TABLE 174: Antibiotics Market in India: Percentage Share Breakdown of Sales by Route of Administration for 2009, 2019, and 2025
  • SOUTH KOREA
    • TABLE 175: Antibiotics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 176: South Korean Antibiotics Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 177: Antibiotics Market Share Distribution in South Korea by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 178: Antibiotics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Drug Origin for the Period 2018-2025
    • TABLE 179: South Korean Antibiotics Historic Market Analysis in US$ Million by Drug Origin: 2009-2017
    • TABLE 180: Antibiotics Market Share Distribution in South Korea by Drug Origin: 2009 VS 2019 VS 2025
    • TABLE 181: Antibiotics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Route of Administration for the Period 2018-2025
    • TABLE 182: South Korean Antibiotics Historic Market Analysis in US$ Million by Route of Administration: 2009-2017
    • TABLE 183: Antibiotics Market Share Distribution in South Korea by Route of Administration: 2009 VS 2019 VS 2025
  • REST OF ASIA-PACIFIC
    • TABLE 184: Rest of Asia-Pacific Market for Antibiotics: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 185: Antibiotics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
    • TABLE 186: Rest of Asia-Pacific Antibiotics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 187: Rest of Asia-Pacific Market for Antibiotics: Annual Sales Estimates and Projections in US$ Million by Drug Origin for the Period 2018-2025
    • TABLE 188: Antibiotics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Drug Origin for the Period 2009-2017
    • TABLE 189: Rest of Asia-Pacific Antibiotics Market Share Analysis by Drug Origin: 2009 VS 2019 VS 2025
    • TABLE 190: Rest of Asia-Pacific Market for Antibiotics: Annual Sales Estimates and Projections in US$ Million by Route of Administration for the Period 2018-2025
    • TABLE 191: Antibiotics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Route of Administration for the Period 2009-2017
    • TABLE 192: Rest of Asia-Pacific Antibiotics Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025
  • LATIN AMERICA
    • TABLE 193: Latin American Antibiotics Market Trends by Region/Country in US$ Million: 2018-2025
    • TABLE 194: Antibiotics Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
    • TABLE 195: Latin American Antibiotics Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
    • TABLE 196: Latin American Antibiotics Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 197: Antibiotics Historic Market Analysis in Latin America in US$ Million by Drug Class: 2009-2017
    • TABLE 198: Latin American Antibiotics Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 199: Latin American Antibiotics Market Growth Prospects in US$ Million by Drug Origin for the Period 2018-2025
    • TABLE 200: Antibiotics Historic Market Analysis in Latin America in US$ Million by Drug Origin: 2009-2017
    • TABLE 201: Latin American Antibiotics Market by Drug Origin: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 202: Latin American Antibiotics Market Growth Prospects in US$ Million by Route of Administration for the Period 2018-2025
    • TABLE 203: Antibiotics Historic Market Analysis in Latin America in US$ Million by Route of Administration: 2009-2017
    • TABLE 204: Latin American Antibiotics Market by Route of Administration: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • ARGENTINA
    • TABLE 205: Argentinean Antibiotics Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
    • TABLE 206: Antibiotics Market in Argentina in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 207: Argentinean Antibiotics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 208: Argentinean Antibiotics Market Estimates and Forecasts in US$ Million by Drug Origin: 2018-2025
    • TABLE 209: Antibiotics Market in Argentina in US$ Million by Drug Origin: A Historic Review for the Period 2009-2017
    • TABLE 210: Argentinean Antibiotics Market Share Breakdown by Drug Origin: 2009 VS 2019 VS 2025
    • TABLE 211: Argentinean Antibiotics Market Estimates and Forecasts in US$ Million by Route of Administration: 2018-2025
    • TABLE 212: Antibiotics Market in Argentina in US$ Million by Route of Administration: A Historic Review for the Period 2009-2017
    • TABLE 213: Argentinean Antibiotics Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025
  • BRAZIL
    • TABLE 214: Antibiotics Market in Brazil by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 215: Brazilian Antibiotics Historic Market Scenario in US$ Million by Drug Class: 2009-2017
    • TABLE 216: Brazilian Antibiotics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 217: Antibiotics Market in Brazil by Drug Origin: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 218: Brazilian Antibiotics Historic Market Scenario in US$ Million by Drug Origin: 2009-2017
    • TABLE 219: Brazilian Antibiotics Market Share Analysis by Drug Origin: 2009 VS 2019 VS 2025
    • TABLE 220: Antibiotics Market in Brazil by Route of Administration: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 221: Brazilian Antibiotics Historic Market Scenario in US$ Million by Route of Administration: 2009-2017
    • TABLE 222: Brazilian Antibiotics Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025
  • MEXICO
    • TABLE 223: Antibiotics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 224: Mexican Antibiotics Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 225: Mexican Antibiotics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 226: Antibiotics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Drug Origin for the Period 2018-2025
    • TABLE 227: Mexican Antibiotics Historic Market Analysis in US$ Million by Drug Origin: 2009-2017
    • TABLE 228: Mexican Antibiotics Market Share Breakdown by Drug Origin: 2009 VS 2019 VS 2025
    • TABLE 229: Antibiotics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Route of Administration for the Period 2018-2025
    • TABLE 230: Mexican Antibiotics Historic Market Analysis in US$ Million by Route of Administration: 2009-2017
    • TABLE 231: Mexican Antibiotics Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025
  • REST OF LATIN AMERICA
    • TABLE 232: Rest of Latin America Antibiotics Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
    • TABLE 233: Antibiotics Market in Rest of Latin America by Drug Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 234: Rest of Latin America Antibiotics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 235: Rest of Latin America Antibiotics Market Estimates and Projections in US$ Million by Drug Origin: 2018 to 2025
    • TABLE 236: Antibiotics Market in Rest of Latin America by Drug Origin: A Historic Review in US$ Million for 2009-2017
    • TABLE 237: Rest of Latin America Antibiotics Market Share Breakdown by Drug Origin: 2009 VS 2019 VS 2025
    • TABLE 238: Rest of Latin America Antibiotics Market Estimates and Projections in US$ Million by Route of Administration: 2018 to 2025
    • TABLE 239: Antibiotics Market in Rest of Latin America by Route of Administration: A Historic Review in US$ Million for 2009-2017
    • TABLE 240: Rest of Latin America Antibiotics Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025
  • MIDDLE EAST
    • TABLE 241: The Middle East Antibiotics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 242: Antibiotics Market in the Middle East by Region/Country in US$ Million: 2009-2017
    • TABLE 243: The Middle East Antibiotics Market Share Breakdown by Region/Country: 2009, 2019, and 2025
    • TABLE 244: The Middle East Antibiotics Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025
    • TABLE 245: The Middle East Antibiotics Historic Market by Drug Class in US$ Million: 2009-2017
    • TABLE 246: Antibiotics Market in the Middle East: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
    • TABLE 247: The Middle East Antibiotics Market Estimates and Forecasts in US$ Million by Drug Origin: 2018 to 2025
    • TABLE 248: The Middle East Antibiotics Historic Market by Drug Origin in US$ Million: 2009-2017
    • TABLE 249: Antibiotics Market in the Middle East: Percentage Share Breakdown of Sales by Drug Origin for 2009, 2019, and 2025
    • TABLE 250: The Middle East Antibiotics Market Estimates and Forecasts in US$ Million by Route of Administration: 2018 to 2025
    • TABLE 251: The Middle East Antibiotics Historic Market by Route of Administration in US$ Million: 2009-2017
    • TABLE 252: Antibiotics Market in the Middle East: Percentage Share Breakdown of Sales by Route of Administration for 2009, 2019, and 2025
  • IRAN
    • TABLE 253: Iranian Market for Antibiotics: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 254: Antibiotics Market in Iran: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017
    • TABLE 255: Iranian Antibiotics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 256: Iranian Market for Antibiotics: Annual Sales Estimates and Projections in US$ Million by Drug Origin for the Period 2018-2025
    • TABLE 257: Antibiotics Market in Iran: Historic Sales Analysis in US$ Million by Drug Origin for the Period 2009-2017
    • TABLE 258: Iranian Antibiotics Market Share Analysis by Drug Origin: 2009 VS 2019 VS 2025
    • TABLE 259: Iranian Market for Antibiotics: Annual Sales Estimates and Projections in US$ Million by Route of Administration for the Period 2018-2025
    • TABLE 260: Antibiotics Market in Iran: Historic Sales Analysis in US$ Million by Route of Administration for the Period 2009-2017
    • TABLE 261: Iranian Antibiotics Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025
  • ISRAEL
    • TABLE 262: Israeli Antibiotics Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
    • TABLE 263: Antibiotics Market in Israel in US$ Million by Drug Class: A Historic Review for the Period 2009-2017
    • TABLE 264: Israeli Antibiotics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 265: Israeli Antibiotics Market Estimates and Forecasts in US$ Million by Drug Origin: 2018-2025
    • TABLE 266: Antibiotics Market in Israel in US$ Million by Drug Origin: A Historic Review for the Period 2009-2017
    • TABLE 267: Israeli Antibiotics Market Share Breakdown by Drug Origin: 2009 VS 2019 VS 2025
    • TABLE 268: Israeli Antibiotics Market Estimates and Forecasts in US$ Million by Route of Administration: 2018-2025
    • TABLE 269: Antibiotics Market in Israel in US$ Million by Route of Administration: A Historic Review for the Period 2009-2017
    • TABLE 270: Israeli Antibiotics Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025
  • SAUDI ARABIA
    • TABLE 271: Saudi Arabian Antibiotics Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 272: Antibiotics Historic Market Analysis in Saudi Arabia in US$ Million by Drug Class: 2009-2017
    • TABLE 273: Saudi Arabian Antibiotics Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 274: Saudi Arabian Antibiotics Market Growth Prospects in US$ Million by Drug Origin for the Period 2018-2025
    • TABLE 275: Antibiotics Historic Market Analysis in Saudi Arabia in US$ Million by Drug Origin: 2009-2017
    • TABLE 276: Saudi Arabian Antibiotics Market by Drug Origin: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 277: Saudi Arabian Antibiotics Market Growth Prospects in US$ Million by Route of Administration for the Period 2018-2025
    • TABLE 278: Antibiotics Historic Market Analysis in Saudi Arabia in US$ Million by Route of Administration: 2009-2017
    • TABLE 279: Saudi Arabian Antibiotics Market by Route of Administration: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED ARAB EMIRATES
    • TABLE 280: Antibiotics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 281: United Arab Emirates Antibiotics Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 282: Antibiotics Market Share Distribution in United Arab Emirates by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 283: Antibiotics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Drug Origin for the Period 2018-2025
    • TABLE 284: United Arab Emirates Antibiotics Historic Market Analysis in US$ Million by Drug Origin: 2009-2017
    • TABLE 285: Antibiotics Market Share Distribution in United Arab Emirates by Drug Origin: 2009 VS 2019 VS 2025
    • TABLE 286: Antibiotics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Route of Administration for the Period 2018-2025
    • TABLE 287: United Arab Emirates Antibiotics Historic Market Analysis in US$ Million by Route of Administration: 2009-2017
    • TABLE 288: Antibiotics Market Share Distribution in United Arab Emirates by Route of Administration: 2009 VS 2019 VS 2025
  • REST OF MIDDLE EAST
    • TABLE 289: Antibiotics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025
    • TABLE 290: Rest of Middle East Antibiotics Historic Market Analysis in US$ Million by Drug Class: 2009-2017
    • TABLE 291: Rest of Middle East Antibiotics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 292: Antibiotics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Drug Origin for the Period 2018-2025
    • TABLE 293: Rest of Middle East Antibiotics Historic Market Analysis in US$ Million by Drug Origin: 2009-2017
    • TABLE 294: Rest of Middle East Antibiotics Market Share Breakdown by Drug Origin: 2009 VS 2019 VS 2025
    • TABLE 295: Antibiotics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Route of Administration for the Period 2018-2025
    • TABLE 296: Rest of Middle East Antibiotics Historic Market Analysis in US$ Million by Route of Administration: 2009-2017
    • TABLE 297: Rest of Middle East Antibiotics Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025
  • AFRICA
    • TABLE 298: African Antibiotics Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025
    • TABLE 299: Antibiotics Market in Africa by Drug Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 300: African Antibiotics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
    • TABLE 301: African Antibiotics Market Estimates and Projections in US$ Million by Drug Origin: 2018 to 2025
    • TABLE 302: Antibiotics Market in Africa by Drug Origin: A Historic Review in US$ Million for 2009-2017
    • TABLE 303: African Antibiotics Market Share Breakdown by Drug Origin: 2009 VS 2019 VS 2025
    • TABLE 304: African Antibiotics Market Estimates and Projections in US$ Million by Route of Administration: 2018 to 2025
    • TABLE 305: Antibiotics Market in Africa by Route of Administration: A Historic Review in US$ Million for 2009-2017
    • TABLE 306: African Antibiotics Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025

IV. COMPETITION

  • ABBOTT LABORATORIES
  • ALLERGAN PLC
  • AUROBINDO PHARMA
  • BAYER AG
  • ELI LILLY AND COMPANY
  • F. HOFFMANN-LA ROCHE AG
  • GLAXOSMITHKLINE PLC
  • LUPIN PHARMACEUTICALS
  • MERCK & CO., INC.
  • MYLAN NV
  • NOVARTIS INTERNATIONAL AG
  • PFIZER
  • SANOFI
  • SHIONOGI, INC.
  • SUN PHARMACEUTICAL INDUSTRIES
  • TEVA PHARMACEUTICAL INDUSTRIES

V. CURATED RESEARCH

Back to Top